Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 6/10

vs
industry
vs
history
Cash to Debt 0.03
HLS's Cash to Debt is ranked lower than
52% of the 348 Companies
in the Global Medical Care industry.

( Industry Median: 0.19 vs. HLS: 0.03 )
HLS' s 10-Year Cash to Debt Range
Min: 0.02   Max: 9999
Current: 0.03

0.02
9999
Equity to Asset 0.14
HLS's Equity to Asset is ranked lower than
51% of the 339 Companies
in the Global Medical Care industry.

( Industry Median: 0.42 vs. HLS: 0.14 )
HLS' s 10-Year Equity to Asset Range
Min: -0.76   Max: 0.59
Current: 0.14

-0.76
0.59
Interest Coverage 4.28
HLS's Interest Coverage is ranked higher than
60% of the 193 Companies
in the Global Medical Care industry.

( Industry Median: 6.11 vs. HLS: 4.28 )
HLS' s 10-Year Interest Coverage Range
Min: 0.29   Max: 9999.99
Current: 4.28

0.29
9999.99
F-Score: 6
Z-Score: 1.35
M-Score: -2.54
WACC vs ROIC
9.90%
17.06%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 7/10

vs
industry
vs
history
Operating margin (%) 19.69
HLS's Operating margin (%) is ranked higher than
92% of the 349 Companies
in the Global Medical Care industry.

( Industry Median: 9.26 vs. HLS: 19.69 )
HLS' s 10-Year Operating margin (%) Range
Min: -3.55   Max: 37.8
Current: 19.69

-3.55
37.8
Net-margin (%) 9.35
HLS's Net-margin (%) is ranked higher than
85% of the 349 Companies
in the Global Medical Care industry.

( Industry Median: 4.59 vs. HLS: 9.35 )
HLS' s 10-Year Net-margin (%) Range
Min: -36.52   Max: 48.3
Current: 9.35

-36.52
48.3
ROE (%) 54.50
HLS's ROE (%) is ranked higher than
98% of the 330 Companies
in the Global Medical Care industry.

( Industry Median: 11.00 vs. HLS: 54.50 )
HLS' s 10-Year ROE (%) Range
Min: -22.44   Max: 1312.58
Current: 54.5

-22.44
1312.58
ROA (%) 8.01
HLS's ROA (%) is ranked higher than
87% of the 355 Companies
in the Global Medical Care industry.

( Industry Median: 4.18 vs. HLS: 8.01 )
HLS' s 10-Year ROA (%) Range
Min: -17.98   Max: 44.36
Current: 8.01

-17.98
44.36
ROC (Joel Greenblatt) (%) 39.11
HLS's ROC (Joel Greenblatt) (%) is ranked higher than
85% of the 352 Companies
in the Global Medical Care industry.

( Industry Median: 17.58 vs. HLS: 39.11 )
HLS' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -17.71   Max: 129.42
Current: 39.11

-17.71
129.42
Revenue Growth (3Y)(%) 8.70
HLS's Revenue Growth (3Y)(%) is ranked higher than
76% of the 258 Companies
in the Global Medical Care industry.

( Industry Median: 8.50 vs. HLS: 8.70 )
HLS' s 10-Year Revenue Growth (3Y)(%) Range
Min: -27   Max: 8.7
Current: 8.7

-27
8.7
EBITDA Growth (3Y)(%) 14.10
HLS's EBITDA Growth (3Y)(%) is ranked higher than
86% of the 210 Companies
in the Global Medical Care industry.

( Industry Median: 7.30 vs. HLS: 14.10 )
HLS' s 10-Year EBITDA Growth (3Y)(%) Range
Min: 0   Max: 19.8
Current: 14.1

0
19.8
EPS Growth (3Y)(%) 16.40
HLS's EPS Growth (3Y)(%) is ranked higher than
80% of the 198 Companies
in the Global Medical Care industry.

( Industry Median: 9.00 vs. HLS: 16.40 )
HLS' s 10-Year EPS Growth (3Y)(%) Range
Min: -47.9   Max: 56
Current: 16.4

-47.9
56
» HLS's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Guru Trades

Q1 2014

HLS Guru Trades in Q1 2014

Jim Simons 595,800 sh (+2.46%)
Columbia Wanger 2,541,000 sh (unchged)
Paul Tudor Jones Sold Out
Vanguard Health Care Fund Sold Out
Steven Cohen Sold Out
James Barrow 2,990,363 sh (-0.55%)
Chuck Royce 734,800 sh (-5.00%)
Mariko Gordon 1,874,476 sh (-19.70%)
» More
Q2 2014

HLS Guru Trades in Q2 2014

Paul Tudor Jones 6,324 sh (New)
Jim Simons 785,200 sh (+31.79%)
Chuck Royce 796,313 sh (+8.37%)
Mariko Gordon 1,863,584 sh (-0.58%)
Columbia Wanger 2,526,100 sh (-0.59%)
James Barrow 2,890,653 sh (-3.33%)
» More
Q3 2014

HLS Guru Trades in Q3 2014

Paul Tudor Jones 13,585 sh (+114.82%)
Jim Simons 971,400 sh (+23.71%)
Columbia Wanger 2,519,800 sh (-0.25%)
Mariko Gordon 1,857,733 sh (-0.31%)
Chuck Royce 756,513 sh (-5.00%)
James Barrow 2,401,883 sh (-16.91%)
» More
Q4 2014

HLS Guru Trades in Q4 2014

Joel Greenblatt 215,644 sh (New)
Paul Tudor Jones 21,680 sh (+59.59%)
Jim Simons 1,066,400 sh (+9.78%)
Chuck Royce 756,513 sh (unchged)
Mariko Gordon 1,851,856 sh (-0.32%)
Columbia Wanger 2,041,623 sh (-18.98%)
James Barrow 1,884,750 sh (-21.53%)
» More
» Details

Insider Trades

Latest Guru Trades with HLS

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Preferred stocks of Healthsouth Corp

SymbolPriceYieldDescription
HSRPP1557.374.176 1/2% Conv Perp Pfd Shs Series -A-
HLSHP0.000.00Conv Pfd Shs Series A -144A

Ratios

vs
industry
vs
history
P/E(ttm) 20.60
HLS's P/E(ttm) is ranked higher than
87% of the 400 Companies
in the Global Medical Care industry.

( Industry Median: 54.20 vs. HLS: 20.60 )
HLS' s 10-Year P/E(ttm) Range
Min: 1.71   Max: 32.2
Current: 20.6

1.71
32.2
Forward P/E 18.05
HLS's Forward P/E is ranked higher than
82% of the 400 Companies
in the Global Medical Care industry.

( Industry Median: 0.00 vs. HLS: 18.05 )
N/A
PE(NRI) 21.10
HLS's PE(NRI) is ranked higher than
88% of the 400 Companies
in the Global Medical Care industry.

( Industry Median: 48.80 vs. HLS: 21.10 )
HLS' s 10-Year PE(NRI) Range
Min: 1.84   Max: 181.64
Current: 21.1

1.84
181.64
P/B 8.61
HLS's P/B is ranked lower than
57% of the 400 Companies
in the Global Medical Care industry.

( Industry Median: 3.70 vs. HLS: 8.61 )
HLS' s 10-Year P/B Range
Min: 6.91   Max: 191.71
Current: 8.61

6.91
191.71
P/S 1.97
HLS's P/S is ranked higher than
54% of the 400 Companies
in the Global Medical Care industry.

( Industry Median: 1.92 vs. HLS: 1.97 )
HLS' s 10-Year P/S Range
Min: 0.4   Max: 12.07
Current: 1.97

0.4
12.07
PFCF 18.12
HLS's PFCF is ranked higher than
86% of the 400 Companies
in the Global Medical Care industry.

( Industry Median: 99.00 vs. HLS: 18.12 )
HLS' s 10-Year PFCF Range
Min: 1.77   Max: 18.27
Current: 18.12

1.77
18.27
POCF 10.50
HLS's POCF is ranked higher than
85% of the 400 Companies
in the Global Medical Care industry.

( Industry Median: 21.82 vs. HLS: 10.50 )
HLS' s 10-Year POCF Range
Min: 1.53   Max: 10.58
Current: 10.5

1.53
10.58
EV-to-EBIT 13.41
HLS's EV-to-EBIT is ranked higher than
89% of the 400 Companies
in the Global Medical Care industry.

( Industry Median: 31.05 vs. HLS: 13.41 )
HLS' s 10-Year EV-to-EBIT Range
Min: 6   Max: 90.2
Current: 13.41

6
90.2
PEG 1.40
HLS's PEG is ranked higher than
96% of the 400 Companies
in the Global Medical Care industry.

( Industry Median: 0.00 vs. HLS: 1.40 )
HLS' s 10-Year PEG Range
Min: 1.03   Max: 2.66
Current: 1.4

1.03
2.66
Shiller P/E 15.70
HLS's Shiller P/E is ranked higher than
97% of the 400 Companies
in the Global Medical Care industry.

( Industry Median: 0.00 vs. HLS: 15.70 )
HLS' s 10-Year Shiller P/E Range
Min: 5.2   Max: 350
Current: 15.7

5.2
350
Current Ratio 1.88
HLS's Current Ratio is ranked higher than
83% of the 342 Companies
in the Global Medical Care industry.

( Industry Median: 1.34 vs. HLS: 1.88 )
HLS' s 10-Year Current Ratio Range
Min: 0.66   Max: 2.76
Current: 1.88

0.66
2.76
Quick Ratio 1.88
HLS's Quick Ratio is ranked higher than
85% of the 342 Companies
in the Global Medical Care industry.

( Industry Median: 1.12 vs. HLS: 1.88 )
HLS' s 10-Year Quick Ratio Range
Min: 0.66   Max: 2.61
Current: 1.88

0.66
2.61
Days Sales Outstanding 49.69
HLS's Days Sales Outstanding is ranked higher than
73% of the 400 Companies
in the Global Medical Care industry.

( Industry Median: 52.95 vs. HLS: 49.69 )
HLS' s 10-Year Days Sales Outstanding Range
Min: 40.54   Max: 89.44
Current: 49.69

40.54
89.44

Dividend & Buy Back

vs
industry
vs
history
Dividend Yield 1.75
HLS's Dividend Yield is ranked higher than
58% of the 214 Companies
in the Global Medical Care industry.

( Industry Median: 1.44 vs. HLS: 1.75 )
HLS' s 10-Year Dividend Yield Range
Min: 0.5   Max: 2.09
Current: 1.75

0.5
2.09
Dividend Payout 0.35
HLS's Dividend Payout is ranked higher than
87% of the 400 Companies
in the Global Medical Care industry.

( Industry Median: 0.00 vs. HLS: 0.35 )
HLS' s 10-Year Dividend Payout Range
Min: 0.14   Max: 0.34
Current: 0.35

0.14
0.34
Yield on cost (5-Year) 1.70
HLS's Yield on cost (5-Year) is ranked lower than
51% of the 219 Companies
in the Global Medical Care industry.

( Industry Median: 1.73 vs. HLS: 1.70 )
HLS' s 10-Year Yield on cost (5-Year) Range
Min: 0.5   Max: 2.09
Current: 1.7

0.5
2.09
Share Buyback Rate 2.70
HLS's Share Buyback Rate is ranked higher than
95% of the 210 Companies
in the Global Medical Care industry.

( Industry Median: -1.60 vs. HLS: 2.70 )
HLS' s 10-Year Share Buyback Rate Range
Min: 2.7   Max: -31.9
Current: 2.7

Valuation & Return

vs
industry
vs
history
Price/DCF (Projected) 1.27
HLS's Price/DCF (Projected) is ranked higher than
89% of the 400 Companies
in the Global Medical Care industry.

( Industry Median: 0.00 vs. HLS: 1.27 )
HLS' s 10-Year Price/DCF (Projected) Range
Min: 0.85   Max: 209.14
Current: 1.27

0.85
209.14
Price/Median PS Value 1.76
HLS's Price/Median PS Value is ranked higher than
55% of the 400 Companies
in the Global Medical Care industry.

( Industry Median: 1.40 vs. HLS: 1.76 )
HLS' s 10-Year Price/Median PS Value Range
Min: 0.43   Max: 2.69
Current: 1.76

0.43
2.69
Price/Peter Lynch Fair Value 1.29
HLS's Price/Peter Lynch Fair Value is ranked higher than
95% of the 400 Companies
in the Global Medical Care industry.

( Industry Median: 0.00 vs. HLS: 1.29 )
HLS' s 10-Year Price/Peter Lynch Fair Value Range
Min: 0.48   Max: 2.35
Current: 1.29

0.48
2.35
Earnings Yield (Greenblatt) 7.50
HLS's Earnings Yield (Greenblatt) is ranked higher than
86% of the 345 Companies
in the Global Medical Care industry.

( Industry Median: 4.20 vs. HLS: 7.50 )
HLS' s 10-Year Earnings Yield (Greenblatt) Range
Min: 1.1   Max: 16.5
Current: 7.5

1.1
16.5
Forward Rate of Return (Yacktman) 21.53
HLS's Forward Rate of Return (Yacktman) is ranked higher than
90% of the 210 Companies
in the Global Medical Care industry.

( Industry Median: 11.64 vs. HLS: 21.53 )
HLS' s 10-Year Forward Rate of Return (Yacktman) Range
Min: 3.2   Max: 26.7
Current: 21.53

3.2
26.7

Business Description

Industry: Health Care Providers » Medical Care
Compare:CHE, DVA, FSNUY, BDUUF, SKHCY » details
Traded in other countries:HSRPP.USA, HSOA.Germany,
HealthSouth Corp was organized as a Delaware corporation in February 1984. It is a provider of inpatient rehabilitative health care services in the United States. The Company's inpatient rehabilitation hospitals offer specialized rehabilitative care to diagnose and patient care services. Patient care is provided by nursing and therapy staff as directed by a physician order. As of December 31, 2013, it operated 103 inpatient rehabilitation hospitals including 2 hospitals that operate as joint ventures which it account for using the equity method of accounting, 20 outpatient rehabilitation satellite clinics operated by its hospitals and 25 licensed, hospital-based home health agencies. In addition to HealthSouth hospitals, it manages three inpatient rehabilitation units through management contracts. While it's national network of inpatient hospitals in 28 states and Puerto Rico, its inpatient hospitals are located in the eastern half of the United States and Texas. The Company's inpatient rehabilitation hospitals compete with rehabilitation units, many of which are within acute care hospitals, and skilled nursing facilities in the market. It treats patients of all ages. Its patients are persons aged 65 years and older. The Company is subject to significant federal, state, and local regulation.
» More Articles for HLS

Headlines

Articles On GuruFocus.com
Vycor Value Could be Unlocked with These Major Partnerships Dec 05 2014 
26.25% Annual Return With Lobbying Stocks? Here Is How It Works Nov 21 2014 
5 Stocks Building Long-Term Wealth With Increased Dividends Jul 28 2014 
"Thrift, fearlessness, resilience, hard work" - What Makes Mariko Gordon Our Newest Guru Dec 07 2013 
My 5 Favorite High Beta Health Care Dividend Stocks Aug 02 2013 
physical therepy Jan 09 2013 
physical therepy Jan 09 2013 
HEALTHSOUTH Corp. Reports Operating Results (10-K) Feb 24 2011 
HealthSouth Reports Results for Second Quarter 2009 and Increases 2009 Guidance Aug 04 2009 
HealthSouth Declares Dividend on 6.5 Percent Series A Convertible Perpetual Preferred Stock Dec 18 2008 

More From Other Websites
HealthSouth Provides Notice Of Conversion Of The 6.5% Series A Convertible Perpetual Preferred Stock Apr 22 2015
Medicare's (Stay) Home Savings Plan Apr 17 2015
HealthSouth To Hold Annual Stockholder Meeting Apr 13 2015
Doctor on your wrist Apr 13 2015
HEALTHSOUTH CORP Files SEC form 8-K, Termination of a Material Definitive Agreement Apr 10 2015
HealthSouth Announces Date Of 2015 First Quarter Earnings Conference Call Apr 01 2015
HealthSouth And Memorial Health Begin Joint Operations Of Inpatient Rehabilitation Hospital In... Apr 01 2015
HEALTHSOUTH CORP Files SEC form 8-K, Regulation FD Disclosure Mar 27 2015
HEALTHSOUTH CORP Files SEC form 8-K, Regulation FD Disclosure Mar 23 2015
HEALTHSOUTH CORP Files SEC form 8-K, Entry into a Material Definitive Agreement, Other Events,... Mar 12 2015
HealthSouth Announces Pricing Of $300 Million Senior Notes Offering Mar 09 2015
HealthSouth Corporation -- Moody's rates HealthSouth's proposed senior notes Ba3; Ba3 CFR unchanged Mar 09 2015
HealthSouth Announces Launch Of $300 Million Senior Notes Offering Due 2023 And Intent To Redeem... Mar 09 2015
HEALTHSOUTH CORP Files SEC form 8-K, Other Events Mar 09 2015
HEALTHSOUTH CORP Financials Mar 07 2015
10-K for HealthSouth Corp. Mar 05 2015
Acadia, AmSurg Lead In Outpatient Medical Group Mar 02 2015
HEALTHSOUTH CORP Files SEC form 10-K, Annual Report Mar 02 2015
Amsurg (AMSG) Beats Q4 Earnings, Revenues; Outlook Bright - Analyst Blog Feb 26 2015
HealthSouth Revenue Rises 7% Feb 24 2015

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK